Jean Isherwood
Obstetrics & Gynecology · Lexington, SCNPI 1104812403
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Astellas Pharma US Inc accounts for 81.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2023 at $5,511 and has fallen 99.0% since, to $53 in 2025. Among obstetrics & gynecology clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $91.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$5K
- Avion Pharmaceuticals$220
- Exeltis, USA Inc.$160
- AbbVie$95
- Myovant Sciences Inc.$88
- Johnson & Johnson$75
- plus $540 from 14 others
What the payments were for
- Consulting fees$3,48654%
- Travel & lodging$95515%
- Food & beverage$1,90730%
- Education$911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 18 | $5,261 |
| Avion Pharmaceuticals | 1 | $220 |
| Exeltis, USA Inc. | 10 | $160 |
| AbbVie | 6 | $95 |
| Myovant Sciences Inc. | 1 | $88 |
| Johnson & Johnson | 2 | $75 |
| Therapeuticsmd, Inc. | 4 | $73 |
| Dexcom, Inc. | 2 | $63 |
| Daiichi Sankyo Inc. | 3 | $58 |
| Organon | 8 | $55 |
| Pfizer | 2 | $54 |
| Medtronic | 1 | $50 |
| Bayer | 3 | $49 |
| Exact Sciences | 3 | $43 |
| Sage Therapeutics, LLC | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Boston Scientific | 1 | $19 |
| Astellas Pharma Global Development | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Aspira Women's Health Inc | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,439 in reported general payments places this provider in the 90th percentile of 673 obstetrics & gynecology providers in South Carolina.
See all obstetrics & gynecology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 49 | $2,154 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $227 |
| Alendronate Sodium | 12 | $108 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Lexington
- Helen LathamLexington$5K
- Christopher JenningsAnderson$1.3M
- William ColemanGreenville$242K
- Melvin SeidMauldin$235K
- Brooke NaffzigerWest Columbia$70K
- Judith BurgisColumbia$59K
- Charis ChambersGreenville$46K
- Angela ChoiCharleston$43K
- Andrew FuttermanCharleston$38K
- William OttingerCharleston$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.